Danthron

CHEMBL53418 Phase 4 Đã phê duyệt Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
240.2 g/mol
LogP
3.2
Phase
4

A stimulant laxative that promotes bowel movements by irritating the intestinal lining and increasing intestinal contractions. Its use has been restricted in many countries due to concerns about potential carcinogenicity.

Khối lượng phân tử

240,2100 g/mol

LogP

3,20

TPSA

74,60 Ų

Lipinski RO5

Đạt

Cơ chế tác dụng

Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Cơ chế

Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.

Cấu trúc 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

O=C1c2cccc(O)c2C(=O)c2c(O)cccc21

InChI

InChI=1S/C14H8O4/c15-9-5-1-3-7-11(9)14(18)12-8(13(7)17)4-2-6-10(12)16/h1-6,15-16H

Molecular Formula

C14H8O4

HBD / HBA

2 / 4

Liên kết có thể quay

0

Nguyên tử nặng

18

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Câu hỏi thường gặp

A stimulant laxative that promotes bowel movements by irritating the intestinal lining and increasing intestinal contractions. Its use has been restricted in many countries due to concerns about potential carcinogenicity.

Increases water content in the intestinal lumen through osmotic or stimulant mechanisms, promoting bowel motility and facilitating defecation.

Yes, Danthron is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL53418. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 2950. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Tuyên bố miễn trách y tế

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.